PH31621A - Pharmaceutical compositions. - Google Patents

Pharmaceutical compositions.

Info

Publication number
PH31621A
PH31621A PH45577A PH45577A PH31621A PH 31621 A PH31621 A PH 31621A PH 45577 A PH45577 A PH 45577A PH 45577 A PH45577 A PH 45577A PH 31621 A PH31621 A PH 31621A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
psoriasis
malignant
esters
salts
Prior art date
Application number
PH45577A
Other languages
English (en)
Inventor
Bollag Werner
Grippo Joseph Francis
Levin Arthur
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH31621A publication Critical patent/PH31621A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
PH45577A 1992-01-22 1993-01-19 Pharmaceutical compositions. PH31621A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82392892A 1992-01-22 1992-01-22
US82378692A 1992-01-22 1992-01-22
US82374192A 1992-01-22 1992-01-22
US82464792A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
PH31621A true PH31621A (en) 1999-01-12

Family

ID=27505866

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45577A PH31621A (en) 1992-01-22 1993-01-19 Pharmaceutical compositions.

Country Status (20)

Country Link
EP (1) EP0552624B1 (fr)
JP (1) JP3631259B2 (fr)
CN (2) CN1068200C (fr)
AT (1) ATE194077T1 (fr)
AU (1) AU667864B2 (fr)
CA (1) CA2087251C (fr)
CY (1) CY2251B1 (fr)
CZ (1) CZ282548B6 (fr)
DE (1) DE69328910T2 (fr)
DK (1) DK0552624T3 (fr)
ES (1) ES2148184T3 (fr)
GR (1) GR3034323T3 (fr)
HU (2) HU212734B (fr)
IL (1) IL104450A (fr)
NO (1) NO302274B1 (fr)
NZ (1) NZ245686A (fr)
PH (1) PH31621A (fr)
PT (1) PT552624E (fr)
RU (1) RU2119333C1 (fr)
TW (1) TW226329B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056954B2 (en) 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
ATE163544T1 (de) 1991-12-18 1998-03-15 Salk Inst For Biological Studi Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US5821254A (en) * 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
WO1996032935A1 (fr) * 1995-04-21 1996-10-24 Ligand Pharmaceuticals Incorporated Inhibition de l'apoptose dans des cellules exprimant le ligand de fas suite a l'activation
DE19523079A1 (de) * 1995-06-26 1997-01-02 Basf Ag Ester und Amide der 9(Z)-Retinsäure
US6028052A (en) * 1995-09-18 2000-02-22 Ligand Pharmaceuticals Incorporated Treating NIDDM with RXR agonists
KR19990045756A (ko) * 1995-09-18 1999-06-25 윌리암 엘. 레스페스 Ｒｘｒ 작용제를 이용하는 ｎｉｄｄｍ 치료 방법
TW442459B (en) * 1996-04-15 2001-06-23 Hoffmann La Roche Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
FR2765480B1 (fr) 1997-07-07 1999-09-10 Oreal Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
WO1999005161A1 (fr) 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated SEQUENCES REGULATRICES DU GENE HUMAIN PPARη (RECEPTEUR GAMMA ACTIVE DE LA PROLIFERATION DES PEROXYSOMES) ET LEURS UTILISATIONS
WO1999048529A1 (fr) * 1998-03-20 1999-09-30 Warner-Lambert Company Combinaisons retinoides-glitazone
NZ514662A (en) 1999-04-07 2004-01-30 Sankyo Co Amine derivatives
JP5249484B2 (ja) * 2001-12-11 2013-07-31 第一三共株式会社 医薬組成物
US20050245440A1 (en) * 2002-04-05 2005-11-03 University Of Utah Research Foundation Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
AU2003270414A1 (en) * 2002-09-06 2004-03-29 Oregon Health And Science University Effect of vitamin a gel on paranasal sinus mucosal regeneration
EP1527774A1 (fr) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG Formulations nouvelle pour retinoides contenant capsules de gélatine molle
JP4825957B2 (ja) * 2005-03-29 2011-11-30 国立大学法人 鹿児島大学 抗腫瘍剤
AU2009352678B2 (en) 2009-09-15 2015-05-21 Eluminex Biosciences (Suzhou) Limited Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
WO2011129765A1 (fr) * 2010-04-16 2011-10-20 Davos Life Science Pte. Ltd. Interaction synergique d'au moins un constituant de vitamine e et d'inhibiteurs de tyrosinase pour applications dermatologiques
NZ603331A (en) 2010-04-19 2015-02-27 Quadra Logic Tech Inc Therapeutic regimens and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency
MX370928B (es) 2012-03-01 2020-01-08 Retinagenix LLC El uso de 9-cis-retinil acetato para mejorar la función visual de un sujeto que padece de pérdida de la función visual originada por una deficiencia retinoide endógena de 11-cis retinal.
JP6182728B2 (ja) * 2012-11-02 2017-08-23 国立大学法人名古屋大学 幹細胞を標的とした薬効及び毒性の評価法
WO2022051831A1 (fr) 2020-09-11 2022-03-17 Chemyunion Ltda. Composition, utilisation de cette composition, procédé cosmétique et procédé pour moduler la production de sébum
WO2023168608A1 (fr) * 2022-03-08 2023-09-14 Mastery Biotech Co., Ltd. Composition pharmaceutique comprenant de l'acide rétinoïque et un glucide et son utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
AU610587B2 (en) * 1987-04-06 1991-05-23 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid
US4994491A (en) * 1988-12-14 1991-02-19 Molecular Design International Dermal uses of trans-retinoids for the treatment of cancer
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute
ATE163544T1 (de) * 1991-12-18 1998-03-15 Salk Inst For Biological Studi Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen

Also Published As

Publication number Publication date
ES2148184T3 (es) 2000-10-16
HU212734B (en) 1996-10-28
NO930206D0 (no) 1993-01-21
CZ372892A3 (en) 1993-12-15
CN1256916A (zh) 2000-06-21
IL104450A0 (en) 1993-05-13
GR3034323T3 (en) 2000-12-29
ATE194077T1 (de) 2000-07-15
PT552624E (pt) 2000-10-31
RU2119333C1 (ru) 1998-09-27
CA2087251C (fr) 2003-06-24
NZ245686A (en) 1995-05-26
NO302274B1 (no) 1998-02-16
AU667864B2 (en) 1996-04-18
CY2251B1 (en) 2003-07-04
CA2087251A1 (fr) 1993-07-23
DE69328910T2 (de) 2001-01-11
EP0552624A1 (fr) 1993-07-28
HUT63053A (en) 1993-07-28
JP3631259B2 (ja) 2005-03-23
HU211167A9 (en) 1995-11-28
IL104450A (en) 1997-03-18
CN1155376C (zh) 2004-06-30
DK0552624T3 (da) 2000-09-25
TW226329B (fr) 1994-07-11
AU3186193A (en) 1993-07-29
CN1068200C (zh) 2001-07-11
NO930206L (no) 1993-07-23
CN1074826A (zh) 1993-08-04
DE69328910D1 (de) 2000-08-03
HU9300116D0 (en) 1993-04-28
JPH06107542A (ja) 1994-04-19
EP0552624B1 (fr) 2000-06-28
CZ282548B6 (cs) 1997-08-13

Similar Documents

Publication Publication Date Title
PH31621A (en) Pharmaceutical compositions.
RU93005355A (ru) Фармакологические композиции
AU2080988A (en) Esters of 13-trans-retinoic acid
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
AU5471190A (en) Method of topically treating acne vulgaris
MD921G2 (ro) Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
AU6333794A (en) Retinoid composition
KR930016100A (ko) 약제학적 조성물
DE3485337D1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
IT1261696B (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
DE68919009D1 (de) Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
IE873478L (en) Use of 13-cis retinoic acid
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
IT1242478B (it) Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
CA2062422A1 (fr) Methode pour le traitement des patients presentant des lesions precancereuses par l'administration d'acides sulfonylindenylacetiques et sulfonylindenylpropioniques et leurs esters